Abstract
Perinatal asphyxia is a common cause of neurologic morbidity in neonates who are born at term. Asphyxiated neonates are frequently treated with analgesic medications, including opioids, for pain and discomfort associated with their care. On the basis of previous laboratory studies suggesting that opioids may have neuroprotective effects, we conducted a retrospective review of medical records of 52 neonates who were admitted to our neonatal intensive care unit between 1995 and 2002 and had undergone magnetic resonance imaging (MRI) of the brain. Our review revealed that 33% of neonates received morphine or fentanyl. The neonates who received opioids also had experienced hypoxic/ischemic insults of greater magnitude as suggested by higher plasma lactate levels and lower 5-min Apgar scores. It is interesting that the MRI studies of neonates who were treated with opioids during the first week of life demonstrated significantly less brain injury in all regions studied. More important, follow-up studies of a subgroup of opioid-treated neonates whose MRI scans were obtained in the second postnatal week had better long-term neurologic outcomes. Our results suggest that the use of opioids in the first week of life after perinatal asphyxia have no significant long-term detrimental effects and may increase the brain's resistance to hypoxic-ischemic insults.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- BG:
-
basal ganglia
- MRI:
-
magnetic resonance imaging
- NICU:
-
neonatal intensive care unit
- NMDA:
-
N-methyl-d-aspartate
- PCPCS:
-
Pediatric Cerebral Performance Category Scale
- TE:
-
echo time
- TR:
-
repetition time
- W:
-
watershed
- WBC:
-
white blood cell
References
Anand KJ 2000 Effects of perinatal pain and stress. Prog Brain Res 122: 117–129
Heurteaux C, Lauritzen I, Widmann C, Lazdunski M 1995 Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 92: 4666–4670
Anand KJ, Scalzo FM 2000 Can adverse neonatal experiences alter brain development and subsequent behavior?. Biol Neonate 77: 69–82
Pokela ML 1994 Pain relief can reduce hypoxemia in distressed neonates during routine treatment procedures. Pediatrics 93: 379–383
Bennett GJ 2000 Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 19: S2–S6
Olkkola KT, Hamunen K, Maunuksela EL 1995 Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children. Clin Pharmacokinet 28: 385–404
Lee J, Kim MS, Park C, Jung EB, Choi DH, Kim TY, Moon SK, Park R 2004 Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol Immunotoxicol 26: 17–28
Yamakura T, Sakimura K, Shimoji K 1999 Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids. Anesthesiology 91: 1053–1063
Zhang J, Gibney GT, Zhao P, Xia Y 2002 Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol 282: C1225–C1234
Zhang J, Haddad GG, Xia Y 2000 Delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res 885: 143–153
Lim YJ, Zheng S, Zuo Z 2004 Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 100: 562–568
Chien S, Oeltgen PR, Diana JN, Salley RK, Su TP 1994 Extension of tissue survival time in multiorgan block preparation with a delta opioid DADLE ([D-Ala2, D-Leu5]-enkephalin). J Thorac Cardiovasc Surg 107: 964–967
Mayfield KP, D'Alecy LG 1992 Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res 582: 226–231
Mayfield KP, D'Alecy LG 1994 Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 268: 683–688
Barker DP, Rutter N 1996 Stress, severity of illness, and outcome in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 75: F187–F190
Anand KJ, Barton BA, McIntosh N, Lagercrantz H, Pelausa E, Young TE, Vasa R 1999 Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med 153: 331–338
Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Tibboel Dui ven voorden HJ, Bunkers C, Smink E, Anand KJ, van den Ander JND 2003 Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA 290: 2419–2427
Anand KJ, Hall RW, Desai N, Shephard B, Bergqvist LL, Young TE, Boyle EM, Carbajal R, Bhutani VK, Moore MB, Kronsberg SS, Barton BA, NEOPAIN Trial Investigators Group 2004 Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 363: 1673–1682
Jensen F, Tsuji M, Offutt M, Firkusny I, Holtzman D 1993 Profound, reversible energy loss in the hypoxic immature rat brain. Brain Res Dev Brain Res 73: 99–105
Hattori H, Wasterlain CG 1990 Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity. Pediatr Neurol 6: 219–228
Simons SH, van Dijk M, Anand KS, Roofthooft D, van Lingen RA, Tibboel D 2003 Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med 157: 1058–1064
Stevens B, McGrath P, Gibbins S, Beyene J, Breau L, Camfield C, Finley A, Franck L, Howlett A, McKeever P, O'Brien K, Ohlsson A, Yamada J 2003 Procedural pain in newborns at risk for neurologic impairment. Pain 105: 27–35
Nelson KB 2003 Can we prevent cerebral palsy?. N Engl J Med 349: 1765–1769
American Academy of Pediatrics Committee on Substance Abuse and Committee on Children with Disabilities 2000 Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics 106: 358–361
Pasternak JF, Gorey MT 1998 The syndrome of acute near-total intrauterine asphyxia in the term infant. Pediatr Neurol 18: 391–398
Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen F, Ferriero DM 1998 Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol 19: 143–149
Ashwal S, Holshouser BA, Tomas LG, Shu S, Perkin RM, Nystrom GA, Hinshaw DB Jr 1997 1H-magnetic resonance spectroscopy-determined cerebral lactate and poor neurological outcomes in children with central nervous system disease. Ann Neurol 41: 470–481
Fiser DH 1992 Assessing the outcome of pediatric intensive care. J Pediatr 121: 68–74
Fiser DH, Long N, Roberson PK, Hefley G, Zolten K, Brodie-Fowler M 2000 Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments. Crit Care Med 28: 2616–2620
Hajnal BL, Sahebkar-Moghaddam F, Barnwell AJ, Barkovich AJ, Ferriero DM 1999 Early prediction of neurologic outcome after perinatal depression. Pediatr Neurol 21: 788–793
Green CR, Wheeler JR, LaPorte F 2003 Clinical decision making in pain management: contributions of physician and patient characteristics to variations in practice. J Pain 4: 29–39
Pasternak GW 1993 Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16: 1–18
Deleted in proof.
Deleted in proof.
Armstead WM 1995 The contribution of delta 1- and delta 2-opioid receptors to hypoxia-induced pial artery dilation in the newborn pig. J Cereb Blood Flow Metab 15: 539–546
du Plessis AJ, Volpe JJ 2002 Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 15: 151–157
Hamrick SE, Ferriero DM 2003 The injury response in the term newborn brain: can we neuroprotect?. Curr Opin Neurol 16: 147–154
Rutherford M 2002 MRI of the Neonatal Brain. WB Saunders, London, pp 99–128
Dominguez KD, Lomako DM, Katz RW, Kelly HW 2003 Opioid withdrawal in critically ill neonates. Ann Pharmacother 37: 473–477
Stiene-Martin A, Knapp PE, Martin K, Gurwell JA, Ryan S, Thornton SR, Smith FL, Hauser KF 2001 Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo. Glia 36: 78–88
Kofke WA, Garman RH, Garman R, Rose ME 1999 Opioid neurotoxicity: fentanyl-induced exacerbation of cerebral ischemia in rats. Brain Res 818: 326–334
Schultz JE, Hsu AK, Gross GJ 1996 Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100–1104
Reshef A, Sperling O, Zoref-Shani E 2000 The adenosine-induced mechanism for the acquisition of ischemic tolerance in primary rat neuronal cultures. Pharmacol Ther 87: 151–159
Li H, Henry JL 2000 Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro. Eur J Pharmacol 407: 237–244
Peart JN, Gross GJ 2003 Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol 285: H81–H89
Halimi G, Devaux C, Clot-Faybesse O, Sampol J, Legof L, Rochat H, Guieu R 2000 Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur J Pharmacol 398: 217–224
Saugstad OD 1996 Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 98: 103–107
Siesjo BK 1989 Calcium and cell death. Magnesium 8: 223–237
Siesjo BK, Bengtsson F 1989 Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 9: 127–140
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by National Institutes of Health Grant NR8116.
Rights and permissions
About this article
Cite this article
Angeles, D., Wycliffe, N., Michelson, D. et al. Use of Opioids in Asphyxiated Term Neonates: Effects on Neuroimaging and Clinical Outcome. Pediatr Res 57, 873–878 (2005). https://doi.org/10.1203/01.PDR.0000157676.45088.8C
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000157676.45088.8C
This article is cited by
-
Practical approaches to sedation and analgesia in the newborn
Journal of Perinatology (2021)
-
Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia
Journal of Perinatology (2021)
-
Opioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates
Journal of Perinatology (2020)
-
Pharmacological approaches to the management of pain in the neonatal intensive care unit
Journal of Perinatology (2007)
-
Prospective sonographic evaluation of fentanyl side effects on the neonatal gallbladder
European Journal of Clinical Pharmacology (2006)
